Literature DB >> 1711793

Clear cell tumor of the lung. Immunohistochemical and ultrastructural evidence of melanogenesis.

M J Gaffey1, S E Mills, R J Zarbo, L M Weiss, A M Gown.   

Abstract

Clear cell tumors of the lung (CCTL) are rare neoplasms of uncertain differentiation. A previous study of eight CCTL demonstrated a lack of epithelial features, but their exact nature remained unknown. In the current study of nine CCTL, immunohistochemistry using preliminary enzymatic digestion showed strong reactivity with the antimelanocytic markers HMB-45 (seven cases) and HMB-50 (six cases) and focal positivity for S-100 (nine cases), neuron-specific enolase (three cases), synaptophysin (one case), and Leu-7 (one case). Staining for cytokeratin, epithelial membrane antigen, chromogranin, and glial fibrillary acid protein was uniformly negative. Frozen-section immunoreactivity for vimentin and the antimelanocytic monoclonal preparation NKI/BETEB was noted in the one CCTL for which snap-frozen tissue was available. Ultrastructural examination of three glutaraldehyde-fixed CCTL showed rare neoplastic cells containing the full spectrum of melanosomes in two, one of which also contained neurosecretory-type granules. Aberrant melanosomal forms were identified in the third case. Melanosomes were not identified in the remaining five CCTL studied from formalin- or paraffin-retrieved material. The findings indicate that CCTL exhibits melanocytic differentiation. This feature may be of considerable value in distinguishing CCTL from other clear cell neoplasms.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1711793     DOI: 10.1097/00000478-199107000-00005

Source DB:  PubMed          Journal:  Am J Surg Pathol        ISSN: 0147-5185            Impact factor:   6.394


  20 in total

Review 1.  Perivascular epithelioid tumours (PEComas) of the gynaecological tract.

Authors:  Niamh Conlon; Robert A Soslow; Rajmohan Murali
Journal:  J Clin Pathol       Date:  2015-03-06       Impact factor: 3.411

2.  Cathepsin K expression in clear cell "sugar" tumor (PEComa) of the lung.

Authors:  Anna Caliò; Maria Cecilia Mengoli; Alberto Cavazza; Giulio Rossi; Claudio Ghimenton; Matteo Brunelli; Maurizio Pea; Marco Chilosi; Lisa Marcolini; Guido Martignoni
Journal:  Virchows Arch       Date:  2018-03-07       Impact factor: 4.064

Review 3.  [Perivascular neoplasms of skin and soft tissues. A review].

Authors:  T Mentzel
Journal:  Pathologe       Date:  2005-03       Impact factor: 1.011

4.  Clear cell tumor of the lung.

Authors:  Toshiki Hirata; Tetsushi Otani; Sachiko Minamiguchi
Journal:  Int J Clin Oncol       Date:  2006-12-25       Impact factor: 3.402

Review 5.  Perivascular epithelioid cell tumors (PEComas) of the head and neck: report of three cases and review of the literature.

Authors:  Anshu Bandhlish; E Leon Barnes; Joseph T Rabban; Jonathan B McHugh
Journal:  Head Neck Pathol       Date:  2011-05-31

6.  Perivascular epithelioid cell neoplasm of the colon.

Authors:  Hugh James Freeman; Doug L Webber
Journal:  World J Gastrointest Oncol       Date:  2010-04-15

7.  Clear cell "sugar" tumor of the lung: benign or malignant?

Authors:  Albert H Olivencia-Yurvati; Abraham Elias Rodriguez
Journal:  Int Surg       Date:  2015-05

8.  Melanoma-associated antigens in tumours of the nervous system: an immunohistochemical study with the monoclonal antibody HMB-45.

Authors:  C Zimmer; J Gottschalk; S Goebel; J Cervos-Navarro
Journal:  Virchows Arch A Pathol Anat Histopathol       Date:  1992

Review 9.  Primary perivascular epithelioid cell tumor (PEComa) of the liver: report of a case.

Authors:  Janusz M Strzelczyk; Adam Durczynski; Dariusz Szymanski; Maciej Jablkowski; Daniela Dworniak; Stanislaw Sporny
Journal:  Surg Today       Date:  2009-09-27       Impact factor: 2.549

10.  Perivascular epithelioid cell tumor (PEComa) of abdominal cavity from falciform ligament: a case report.

Authors:  Cheol Woong Choi; Tae Oh Kim; Kyung Yeob Kim; Sun Mi Lee; Gwang Ha Kim; Dae Hwan Kang; Geun Am Song; Suk Kim; Dae Hwan Kim
Journal:  J Korean Med Sci       Date:  2009-04-20       Impact factor: 2.153

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.